Shun Kaneko

1.6k total citations
55 papers, 695 citations indexed

About

Shun Kaneko is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shun Kaneko has authored 55 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 36 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Shun Kaneko's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (18 papers). Shun Kaneko is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (18 papers). Shun Kaneko collaborates with scholars based in Japan, United States and France. Shun Kaneko's co-authors include Masayuki Kurosaki, Namiki Izumi, Mamoru Watanabe, Miyako Murakawa, Nobuharu Tamaki, Yasuhiro Asahina, Mayu Higuchi, Jun Itakura, Hiroyuki Nakanishi and Yasuhiro Itsui and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Shun Kaneko

50 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shun Kaneko Japan 14 524 522 62 50 44 55 695
Valérie Oulès France 12 344 0.7× 327 0.6× 33 0.5× 24 0.5× 33 0.8× 25 439
Fred Poordad United States 14 487 0.9× 469 0.9× 50 0.8× 52 1.0× 100 2.3× 45 586
Marta Borghi Italy 14 442 0.8× 485 0.9× 53 0.9× 18 0.4× 28 0.6× 45 579
Sujan Ravi United States 8 233 0.4× 277 0.5× 59 1.0× 49 1.0× 12 0.3× 18 402
Luciana Kikuchi Brazil 13 263 0.5× 240 0.5× 68 1.1× 52 1.0× 13 0.3× 22 417
Aline Lopes Chagas Brazil 13 293 0.6× 244 0.5× 59 1.0× 86 1.7× 16 0.4× 38 447
Wiesław Kryczka Poland 12 479 0.9× 483 0.9× 106 1.7× 24 0.5× 51 1.2× 34 651
Kazuyuki Mizuno Japan 11 215 0.4× 221 0.4× 73 1.2× 34 0.7× 13 0.3× 41 381
Masato Nakai Japan 15 364 0.7× 302 0.6× 102 1.6× 64 1.3× 36 0.8× 56 598
Katsumi Aoyagi Japan 12 506 1.0× 551 1.1× 136 2.2× 14 0.3× 86 2.0× 36 860

Countries citing papers authored by Shun Kaneko

Since Specialization
Citations

This map shows the geographic impact of Shun Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Kaneko more than expected).

Fields of papers citing papers by Shun Kaneko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Kaneko. The network helps show where Shun Kaneko may publish in the future.

Co-authorship network of co-authors of Shun Kaneko

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Kaneko. A scholar is included among the top collaborators of Shun Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Kaneko. Shun Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaneko, Shun, et al.. (2025). Physical Properties for Novel Cilostazol Co-amorphous; Effect of Preparation Method and Molar Ratio on the Co-amorphous. Chemical and Pharmaceutical Bulletin. 73(4). 318–326. 1 indexed citations
2.
Kaneko, Shun, Miyako Murakawa, Jun Tsuchiya, et al.. (2025). Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series. Clinical Journal of Gastroenterology. 18(5). 899–904.
3.
Miyoshi, Masato, Sei Kakinuma, Taro Shimizu, et al.. (2025). Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids. Stem Cell Reports. 20(10). 102642–102642.
4.
Tsuchiya, Jun, Masato Miyoshi, Sei Kakinuma, et al.. (2024). Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model. Cellular and Molecular Gastroenterology and Hepatology. 19(2). 101422–101422. 1 indexed citations
5.
Kaneko, Shun, Yasuhiro Asahina, Miyako Murakawa, et al.. (2024). Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades. PLoS ONE. 19(3). e0297882–e0297882.
6.
Miyoshi, Masato, Sei Kakinuma, Ayako Sato, et al.. (2024). A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1 – JNK pathway‐dependent chemokines. The FASEB Journal. 38(13). e23757–e23757. 2 indexed citations
7.
Suzuki, Tatsuya, Yuka Hayakawa, Shun Kaneko, et al.. (2024). Granulomatous hepatitis with Crohn’s disease: a case report. Clinical Journal of Gastroenterology. 17(3). 551–556.
8.
Takahama, Shokichi, Sachiyo Yoshio, Ryotaro Sakamori, et al.. (2023). Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality. Frontiers in Immunology. 14. 1257113–1257113. 7 indexed citations
9.
Shimakami, Tetsuro, Hiroko Setoyama, Noriko Oza, et al.. (2023). Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan. Journal of Gastroenterology. 58(3). 257–267. 2 indexed citations
10.
Kaneko, Shun, Masayuki Kurosaki, Toshie Mashiba, et al.. (2022). Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B. Journal of Medical Virology. 95(1). e28210–e28210. 4 indexed citations
11.
Sekiguchi, Shuhei, Kaoru Tsuchiya, Yutaka Yasui, et al.. (2022). Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy. Cancer Reports. 5(11). e1613–e1613. 9 indexed citations
12.
13.
Kirino, Sakura, Nobuharu Tamaki, Masayuki Kurosaki, et al.. (2021). Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. Journal of Viral Hepatitis. 28(5). 787–794. 5 indexed citations
14.
Kaneko, Shun, Yoko Nukui, Takeshi Arashiro, et al.. (2020). Clinical validation of an immunochromatographic SARS‐Cov‐2 IgM/IgG antibody assay with Japanese cohort. Journal of Medical Virology. 93(1). 569–572. 8 indexed citations
15.
Tamaki, Nobuharu, Masayuki Kurosaki, Yuka Takahashi, et al.. (2020). Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. International Journal of Molecular Sciences. 22(1). 40–40. 9 indexed citations
16.
Kaneko, Shun, Masayuki Kurosaki, Kaoru Nagata, et al.. (2020). Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity. PLoS ONE. 15(11). e0241663–e0241663. 7 indexed citations
17.
Tamaki, Nobuharu, Mayu Higuchi, Masayuki Kurosaki, et al.. (2019). Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease. Scientific Reports. 9(1). 10109–10109. 27 indexed citations
18.
Nagata, Hiroko, Mina Nakagawa, Yasuhiro Asahina, et al.. (2017). Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. Journal of Hepatology. 67(5). 933–939. 139 indexed citations
19.
20.
Tanaka, Hisashi, Toshiaki Saito, Shun Kaneko, et al.. (1999). [Small cell lung cancer associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].. PubMed. 37(12). 992–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Oulès Breakdown of academic impact, for papers by Fred Poordad Breakdown of academic impact, for papers by Marta Borghi Breakdown of academic impact, for papers by Sujan Ravi Breakdown of academic impact, for papers by Luciana Kikuchi Breakdown of academic impact, for papers by Aline Lopes Chagas Breakdown of academic impact, for papers by Wiesław Kryczka Breakdown of academic impact, for papers by Kazuyuki Mizuno Breakdown of academic impact, for papers by Masato Nakai Breakdown of academic impact, for papers by Katsumi Aoyagi
Rankless by CCL
2026